Investors are constantly seeking chances to make lucrative bets, and one such chance can be purchasing shares of Zydus Lifesciences. Zydus Lifesciences has seen constant growth over the past few years as the pharmaceutical business has continued to flourish. The question of whether it is a solid company to buy and what its share price objective could be in the following years has arisen as a result of this. In this piece, we’ll examine the company’s financial record in more detail, examine patterns and future expectations, and consider if Zydus Lifesciences shares would be a good long-term investment.
Below are the trading platforms that you can use to purchase Zydus Lifescience Ltd shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
Zydus Lifesciences Q3FY24 Highlights
- Zydus Lifesciences witnessed a significant 27% year-on-year increase in net profit during Q3FY24, reaching Rs 790 crore.
- The company’s revenue also saw a notable uptick, climbing to Rs 4,505 crore compared to Rs 4,257 crore in the corresponding period last year.
- This impressive performance was primarily driven by a strong recovery in the domestic formulations segment and resilient sales in the US market.
- Additionally, Zydus Lifesciences’ board of directors approved a share buyback program worth up to Rs 600 crore, indicating confidence in the company’s financial position and growth prospects.
- Managing Director Sharvil Patel expressed optimism about the company’s future growth trajectory, citing a differentiated product portfolio in the US market and the continued success of key brands as key drivers.
- Patel reaffirmed the company’s commitment to achieving healthy double-digit revenue growth by the conclusion of the fiscal year 2024.
| When | Maximum Price | Minimum Price |
|---|---|---|
| March 2024 | ₹940.50 | ₹817.83 |
| April 2024 | ₹913.11 | ₹794.01 |
| May 2024 | ₹899.61 | ₹782.27 |
| June 2024 | ₹932.00 | ₹810.43 |
| July 2024 | ₹922.68 | ₹802.33 |
| August 2024 | ₹959.59 | ₹834.42 |
| September 2024 | ₹997.97 | ₹867.80 |
| October 2024 | ₹978.40 | ₹850.78 |
| November 2024 | ₹1,007.75 | ₹876.31 |
| December 2024 | ₹1,032.95 | ₹898.21 |
2024 Zydus Lifesciences is anticipated to witness fluctuating prices, gradually ascending from March to December. Maximum prices are forecasted to increase from ₹940.50 in March to ₹1,032.95 by December, illustrating a continuous upward trajectory. Likewise, minimum prices are expected to climb from ₹817.83 in March to ₹898.21 by December, indicating consistent growth over the year.
| When | Maximum Price | Minimum Price |
|---|---|---|
| January 2025 | ₹1,053.61 | ₹810.47 |
| February 2025 | ₹1,080.62 | ₹831.25 |
| March 2025 | ₹1,122.77 | ₹863.67 |
| April 2025 | ₹1,100.75 | ₹846.73 |
| May 2025 | ₹1,068.69 | ₹822.07 |
| June 2025 | ₹1,116.78 | ₹859.06 |
| July 2025 | ₹1,094.88 | ₹842.22 |
| August 2025 | ₹1,128.75 | ₹868.27 |
| September 2025 | ₹1,168.25 | ₹898.66 |
| October 2025 | ₹1,198.63 | ₹922.02 |
| November 2025 | ₹1,228.59 | ₹945.07 |
| December 2025 | ₹1,259.31 | ₹968.70 |
In 2025, Zydus Lifesciences is anticipated to witness a progressive trend in prices, with both maximum and minimum prices showing a steady increase month by month. Starting from January with maximum and minimum prices at ₹1,053.61 and ₹810.47 respectively, prices are expected to rise gradually, culminating in December with maximum and minimum prices reaching ₹1,259.31 and ₹968.70 respectively. This consistent upward trajectory suggests a positive outlook for Zydus Lifesciences in the year 2025.
| When | Maximum Price | Minimum Price |
|---|---|---|
| January 2026 | ₹1,297.09 | ₹997.76 |
| February 2026 | ₹1,330.34 | ₹1,023.34 |
| March 2026 | ₹1,382.23 | ₹1,063.25 |
| April 2026 | ₹1,355.13 | ₹1,042.40 |
| May 2026 | ₹1,315.66 | ₹1,012.04 |
| June 2026 | ₹1,374.86 | ₹1,057.59 |
| July 2026 | ₹1,347.90 | ₹1,036.85 |
| August 2026 | ₹1,389.59 | ₹1,068.92 |
| September 2026 | ₹1,438.20 | ₹1,106.33 |
| October 2026 | ₹1,475.62 | ₹1,135.09 |
| November 2026 | ₹1,512.51 | ₹1,163.47 |
| December 2026 | ₹1,550.32 | ₹1,192.56 |
| When | Maximum Price | Minimum Price |
|---|---|---|
| January 2027 | ₹1,581.33 | ₹1,216.41 |
| February 2027 | ₹1,621.88 | ₹1,247.60 |
| March 2027 | ₹1,685.13 | ₹1,296.25 |
| April 2027 | ₹1,652.09 | ₹1,270.84 |
| May 2027 | ₹1,603.97 | ₹1,233.82 |
| June 2027 | ₹1,676.15 | ₹1,289.34 |
| July 2027 | ₹1,643.28 | ₹1,264.06 |
| August 2027 | ₹1,694.10 | ₹1,303.16 |
| September 2027 | ₹1,753.40 | ₹1,348.77 |
| October 2027 | ₹1,798.99 | ₹1,383.84 |
| November 2027 | ₹1,843.96 | ₹1,418.43 |
| December 2027 | ₹1,890.06 | ₹1,453.89 |
| When | Maximum Price | Minimum Price |
|---|---|---|
| January 2028 | ₹1,927.86 | ₹1,482.97 |
| February 2028 | ₹1,977.29 | ₹1,521.00 |
| March 2028 | ₹2,054.41 | ₹1,580.31 |
| April 2028 | ₹2,014.13 | ₹1,549.33 |
| May 2028 | ₹1,955.46 | ₹1,504.20 |
| June 2028 | ₹2,043.46 | ₹1,571.89 |
| July 2028 | ₹2,003.39 | ₹1,541.07 |
| August 2028 | ₹2,065.35 | ₹1,588.73 |
| September 2028 | ₹2,137.64 | ₹1,644.34 |
| October 2028 | ₹2,193.22 | ₹1,687.09 |
| November 2028 | ₹2,248.05 | ₹1,729.27 |
| December 2028 | ₹2,304.25 | ₹1,772.50 |
| When | Maximum Price | Minimum Price |
|---|---|---|
| January 2029 | ₹2,350.33 | ₹1,807.95 |
| February 2029 | ₹2,410.60 | ₹1,854.31 |
| March 2029 | ₹2,504.61 | ₹1,926.62 |
| April 2029 | ₹2,455.50 | ₹1,888.85 |
| May 2029 | ₹2,383.98 | ₹1,833.83 |
| June 2029 | ₹2,491.26 | ₹1,916.35 |
| July 2029 | ₹2,442.41 | ₹1,878.78 |
| August 2029 | ₹2,517.95 | ₹1,936.89 |
| September 2029 | ₹2,606.08 | ₹2,004.68 |
| October 2029 | ₹2,673.84 | ₹2,056.80 |
| November 2029 | ₹2,740.68 | ₹2,108.22 |
| December 2029 | ₹2,809.20 | ₹2,160.92 |
| When | Maximum Price | Minimum Price |
|---|---|---|
| January 2030 | ₹2,865.38 | ₹2,204.14 |
| February 2030 | ₹2,938.86 | ₹2,260.66 |
| March 2030 | ₹3,053.47 | ₹2,348.82 |
| April 2030 | ₹2,993.60 | ₹2,302.77 |
| May 2030 | ₹2,906.41 | ₹2,235.70 |
| June 2030 | ₹3,037.20 | ₹2,336.30 |
| July 2030 | ₹2,977.64 | ₹2,290.49 |
| August 2030 | ₹3,069.74 | ₹2,361.33 |
| September 2030 | ₹3,177.18 | ₹2,443.98 |
| October 2030 | ₹3,259.78 | ₹2,507.52 |
| November 2030 | ₹3,341.28 | ₹2,570.21 |
| December 2030 | ₹3,424.81 | ₹2,634.47 |
Financial Condition of Zydus Lifescience: Last 5 years
| Financial Figures | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| Sales (Rs. Crores) | 13,166 | 14,253 | 14,404 | 15,265 | 17,237 |
| Expenses (Rs. Crores) | 10,174 | 11,455 | 11,013 | 11,923 | 13,378 |
| Operating Profit (Rs. Crores) | 2,991 | 2,798 | 3,391 | 3,342 | 3,860 |
| Other Income (Rs. Crores) | 183 | -264 | -231 | 2,581 | -422 |
| Interest (Rs. Crores) | 194 | 342 | 159 | 127 | 130 |
| Depreciation (Rs. Crores) | 599 | 696 | 670 | 713 | 723 |
| Profit before tax (Rs. Crores) | 2,382 | 1,495 | 2,331 | 5,084 | 2,585 |
| Net Profit (Rs. Crores) | 1,899 | 1,204 | 2,185 | 4,618 | 2,092 |
| Earnings Per Share (EPS) | 18.06 | 11.49 | 20.84 | 43.83 | 19.37 |
| Dividend Payout % | 19% | 30% | 17% | 6% | 31% |
Over the past five years, Zydus Lifesciences has showcased a commendable financial performance, reflecting its strong position in the pharmaceutical industry. With consistent growth in sales, reaching an impressive ₹17,237 crores in March 2023, the company has demonstrated its ability to capture market opportunities. Despite facing various challenges, Zydus effectively managed its expenses, ensuring profitability and maintaining a positive operating profit margin. The company’s focus on innovation is evident through its diverse portfolio, which includes biosimilars, new drugs, and vaccines. With an extensive pipeline of 8 novel biologics and 22 biosimilars, Zydus is poised for continued success in the future.
Additionally, the recent buyback resolution further signifies the company’s commitment to returning value to shareholders, utilizing funds from the sale of its India-centric animal health business undertaking. Zydus Lifesciences stands as a formidable player in the pharmaceutical landscape, leveraging its expertise to drive sustainable growth and deliver cutting-edge healthcare solutions.
FAQS
As of 25th February ’24, the current share price of Zydus Lifesciences is ₹ 923.
Zydus Lifesciences’ share prices ranging from a projected high of ₹1,259.31 to a anticipated low of ₹810.47.
The maximum price prediction for 2030 is ₹3,424.81 and the minimum is ₹2,204.14.
Some of the factors that may impact Zydus Lifesciences’ share price target include the company’s financial performance, changes in industry regulations, and global economic conditions.
Has Zydus Lifesciences’ revenue grown in the past few years?
Yes, Zydus Lifesciences has witnessed a revenue growth of approximately 31.3% from 2019 to 2023.
What is Zydus Lifesciences’ dividend payout ratio?
Zydus Lifesciences’ dividend payout ratio exhibited a fluctuation between 19% and 31% during the period spanning from 2019 to 2023.
What is Zydus Lifesciences’ operating profit margin (OPM)?
Zydus Lifesciences’ operating profit margin (OPM) has remained relatively stable over the past few years, ranging between 19.63% and 23.78%.
Zydus Lifesciences’ EPS has grown significantly over the past five years, from INR 17.35 in 2019 to INR 43.83 in 2023.
As with any investment, it is important to conduct thorough research and analysis before making a decision. While some analysts predict growth for the company, it is important to consider various factors that may impact the share price target in the coming years.
ALSO READ:
- UNITED SPIRITS LTD SHARE PRICE TARGET 2024-2030
- BOSCH LTD SHARE PRICE TARGET 2024-2030
- SHRIRAM FINANCE LTD SHARE PRICE TARGET 2024-2030
CONCLUSION
Zydus Lifesciences offers an enticing investment opportunity within the pharmaceutical sector. With consistent financial growth, highlighted by strong revenue and prudent expense management, the company has solidified its position in the market. The recent approval of a share buyback program underscores management’s confidence and commitment to enhancing shareholder value. With an innovative product portfolio and strategic initiatives, Zydus Lifesciences is well-positioned for continued success in the evolving healthcare landscape, making it a compelling option for long-term investors.
What did we learn?
- 1 How to purchase Zydus Lifescience shares?
- 2 Zydus Lifesciences Q3FY24 Highlights
- 3 Zydus Lifesciences Share Price Target: 2024, 2025 to 2030
- 3.1 Zydus Lifesciences Share Price Target 2024
- 3.2 Zydus Lifesciences Share Price Target 2025
- 3.3 Zydus Lifesciences Share Price Prediction 2026
- 3.4 Zydus Lifesciences Share Price Prediction 2027
- 3.5 Zydus Lifesciences Share Price Prediction 2028
- 3.6 Zydus Lifesciences Share Price Prediction 2029
- 3.7 Zydus Lifesciences Share Price Prediction 2030
- 4 Financial Condition of Zydus Lifescience: Last 5 years
- 5 FAQS
- 5.1 What is the current share price of Zydus Lifesciences?
- 5.2 What is the predicted share price target for Zydus Lifesciences by 2025?
- 5.3 What is the predicted share price target for Zydus Lifesciences by 2030?
- 5.4 What are some of the factors that may impact Zydus Lifesciences’ share price target in the coming years?
- 5.5 Has Zydus Lifesciences’ revenue grown in the past few years?
- 5.6 What is Zydus Lifesciences’ dividend payout ratio?
- 5.7 What is Zydus Lifesciences’ operating profit margin (OPM)?
- 5.8 What is the company’s EPS (Earnings per share)?
- 5.9 Is it a good time to buy Zydus Lifesciences shares?
- 6 CONCLUSION
Twitter
Linkedin
